EUCTR2005-003374-24-IT进行中（未招募）不适用
A phase 2, controlled, multi-center pilot study to evaluate the efficacy and safety of Deligoparin in subjects with retinal vein occlusion of recent onset.
OPOCRIN S.P.A.0 个研究点目标入组 70 人开始时间: 2005年8月11日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
ong-Term Antibody Persistence at 1, 3 and 5 Years After a fourth dose of GSK Biologicals' Hib-MenCY-TT Vaccine compared to Ac-tHIB.Invasive disease caused by Haemophilus type b and Neisseria meningitidis serogroups C and YMedDRA version: 18.0Level: LLTClassification code 10028910Term: Neisseria meningitides meningitisSystem Organ Class: 100000004862MedDRA version: 18.0Level: LLTClassification code 10051931Term: Neisseria infection NOSSystem Organ Class: 100000004862EUCTR2012-004060-22-Outside-EU/EEAGlaxoSmithKline Biologicals443
进行中（未招募）
1 期
Study to assess the efficacy and safety of treatment with FOLFIRI-aflibercept compared to initial treatment with FOLFIRI-aflibercept (for 6 cycles) followed by maintenance with 5FU-aflibercept, in an elderly population with metastatic colorectal cancer after failure of an oxaliplatin-based regimeEUCTR2016-004076-21-ESGrupo de Tratamiento de los Tumores Digestivos (TTD)
进行中（未招募）
不适用
Pilot phase 2 clinical trial performed in some hospitals to evaluate the efficacy and the adverse events in a group of patients with active bullous pemphigoid that will receive DF2156A at the dose of 150 mg, oral route, twice a day.active bullous pemphigoidMedDRA version: 14.0Level: LLTClassification code 10006567Term: Bullous pemphigoidSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000756-42-DEDompé s.p.a.12
进行中（未招募）
不适用
pilot phase 2 clinical trial performed in some hospitals to evaluate the efficacy and the adverse events in a group of patients with active bullous pemphigoid that will receive DF2156A at the dose of 150 mg, oral route, twice a day.active bullous pemphigoidMedDRA version: 14.1Level: LLTClassification code 10006567Term: Bullous pemphigoidSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2011-000756-42-ITDOMPE' s.p.a.12
进行中（未招募）
1 期
A trial to understand whether GSK1070806 improves renal transplant function immediately and in the long term after transplantatioDelayed Graft Function in Adult Subjects After Renal Transplantation.MedDRA version: 20.0 Level: HLT Classification code 10074474 Term: Transplantation complications System Organ Class: 100000004863EUCTR2015-002812-33-GBGlaxoSmithKline Research & Development Ltd7